Jeng-Woei Lee

Title: Innovations in Anti-Cancer Drugs by Jeng-Woei Lee

Introduction

Jeng-Woei Lee is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of anti-cancer drug development. His work focuses on innovative solutions to combat oral cancer, showcasing his dedication to advancing medical science.

Latest Patents

One of Jeng-Woei Lee's key patents is titled "Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs." This invention discloses the use of a polyenylpyrrole derivative synthesized from polyvinylpyrrole, auxarconjugatin A, and 12E-isorumbrin. The derivative has been shown to inhibit cell proliferation, migration, tumor sphere formation abilities, and xenograft tumorigenicity of oral cancer cells. This patent highlights his innovative approach to addressing a critical health issue.

Career Highlights

Jeng-Woei Lee is affiliated with Tzu Chi University, where he conducts research and develops new therapeutic strategies. His work has garnered attention for its potential impact on cancer treatment. With a focus on practical applications, he aims to translate his research into effective medical solutions.

Collaborations

Jeng-Woei Lee collaborates with esteemed colleagues, including Chia-Chen Lau and Yulin Lam. Their combined expertise enhances the research efforts and contributes to the advancement of cancer therapies.

Conclusion

Jeng-Woei Lee's innovative work in the development of anti-cancer drugs exemplifies the importance of research in combating serious health challenges. His contributions are paving the way for new treatment options in the fight against oral cancer.